Clinical Trials Browser

Glioma, Central Nervous System Neoplasms

Clinical Stage I Gastric Cancer AJCC v8

Glioblastoma

Brain Neoplasms, Craniopharyngioma

Oropharyngeal Neoplasms

Sinonasal Squamous Cell Carcinoma

Astrocytoma, Glioblastoma, Gliosarcoma

Anatomic Stage II Breast Cancer AJCC v8

Diabetes Insipidus, Germinoma

Pancreatic Neoplasms

Rectal Neoplasms

Prostatic Neoplasms

Colorectal Neoplasms

Hepatic Veno-Occlusive Disease, Colorectal Neoplasms, Chemical and Drug Induced Liver Injury

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Mouth Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Advanced Biliary Tract Carcinoma

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

MINT-2

A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44)

REGINA

SUGAR

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

SAMe in Prevention of Oxaliplatin-associated Liver Injury

Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery

NBI-CAB

IVIM & OLINK in Sarcoma

GIVEN

Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

N-PLANC

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

InDuRanS